The Federal Register

New Animal Drugs; Change of Sponsor's Name

Wed, Nov 29 2006 11:00:00 GMT

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Bertek Pharmaceuticals, Inc., to Mylan Bertek Pharmaceuticals, Inc.

Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Experimental

Wed, Nov 29 2006 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Experimental Study of Qualified Health Claims: Consumer Inferences About Monounsaturated Fatty Acids From Olive Oil, [eicosapentaenoic acid] EPA and [docosahexaenoic acid] DHA Omega3 Fatty Acids, and Green Tea'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

Transmissible Spongiform Encephalopathies Advisory Committee; Notice of Meeting

Wed, Nov 29 2006 11:00:00 GMT

This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.

[[Page 69135]]

Name of Committee: Transmissible Spongiform Encephalopathies Advisory Committee.

General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues.

Date and Time: The meeting will be held on December 15, 2006, from 8 a.m. to 3:30 p.m.

Location: Crown Plaza Silver Spring, 8777 Georgia Ave., Silver Spring, MD. The hotel telephone number is 3015890800.

Contact Person: William Freas, or Rosanna L. Harvey, Center for Biologics Evaluation and Research (HFM71), Food and Drug
Administration, 1401 Rockville Pike, Rockville, MD 208521448, 301827 0314, or FDA Advisory Committee Information Line, 18007418138 (301 4430572 in the Washington, DC area), code 3014512392. Please call the Information Line for uptodate information on this meeting.

Agenda: On December 15, 200